Guardion Health Sciences: A Look at Financial Results for Q2 2022

Guardion Health Sciences Announces Highest Quarterly Revenue in Company History Viactiv® Product Line Drives Growth Guardion Health Sciences, Inc. (Nasdaq: GHSI) has reported record-breaking revenue of approximately $3.275 million for the most recent quarter. This marks a significant increase from the previous quarter and showcases the company’s continued growth and success in the market. Company…

Read More

Fed’s Daly: The Fight Against Inflation is Far from Over – Insights from the Central Bank

Progress and Challenges in Current Economic Environment The Current State of Inflation and Interest Rates There’s good news on the month-to-month data, showing some signs of improvement in economic indicators. However, inflation remains far too high and is still not near our price stability goal. This is why we can’t afford to declare victory on…

Read More

Breaking News: OrthoPediatrics Corp. Announces Exciting Opportunity for Investors!

OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants Exciting News in Pediatric Orthopedics WARSAW, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) has recently made a significant announcement that has captured the attention of the medical community and investors alike. The Company has commenced an…

Read More

Get Ready to LOL: The Scoop on iTeos’ Second Quarter 2022 Finances and Biz Update!

Hey there, fellow cancer warriors! Let’s talk about iTeos Reports Second Quarter 2022 Financial Results and Business Update So, iTeos has been bustling with activity lately, enrolling patients left and right in their Phase 2 trial expansions. One of the exciting developments is the evaluation of anti-TIGIT monoclonal antibody, EOS-448/GSK4428859A, in combination with GSK’s anti-PD-1…

Read More

Breaking Bones: Rani Therapeutics’ RT-102 Shakes Up Osteoporosis Treatment with Positive Phase 1 Results!

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis Witty, Conversational Blog Post Article: Hey there, lovely readers! Have you heard the latest buzz in the medical world? Rani Therapeutics has just released some exciting news about their Phase 1 study of RT-102 in treating osteoporosis. And let me tell…

Read More

Breaking Records: Aerojet Rocketdyne Delivers 800th THAAD Boost Motor and Control System

Aerojet Rocketdyne Delivers THAAD’s 800th Boost Motor and Divert and Attitude Control System HUNTSVILLE, Ala., Aug. 10, 2022 (GLOBE NEWSWIRE) — Aerojet Rocketdyne has delivered the 800th Solid Rocket Boost Motor and the 800th Divert and Attitude Control System (DACS) for the Terminal High Altitude Area Defense (THAAD) weapon system. THAAD is one of the…

Read More

Revving Up for Success: Automotive HMI Market Set to Reach USD 10.7 Billion by 2030, According to Market Research Future (MRFR) Report

Rising Demand for Enhanced In-Vehicle Experience Boosts the Automotive HMI Market According to a comprehensive research report by Market Research Future (MRFR), the Automotive HMI Market is predicted to garner USD 10,710 Million by 2030, growing at a CAGR of 8.80%. This significant growth is driven by the rising demand for enhanced in-vehicle experience among…

Read More